HK1089170A1 - Processes for the preparation of 1-[(benzoimidazole-1yl)quinolin-8-yl] piperidin-4-ylamine derivatives - Google Patents

Processes for the preparation of 1-[(benzoimidazole-1yl)quinolin-8-yl] piperidin-4-ylamine derivatives

Info

Publication number
HK1089170A1
HK1089170A1 HK06109559A HK06109559A HK1089170A1 HK 1089170 A1 HK1089170 A1 HK 1089170A1 HK 06109559 A HK06109559 A HK 06109559A HK 06109559 A HK06109559 A HK 06109559A HK 1089170 A1 HK1089170 A1 HK 1089170A1
Authority
HK
Hong Kong
Prior art keywords
benzoimidazole
quinolin
piperidin
processes
preparation
Prior art date
Application number
HK06109559A
Other languages
English (en)
Inventor
Tom Norma Jacqueline
Ripin David Harold Brown
Castaldi Michael James
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HK1089170A1 publication Critical patent/HK1089170A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
HK06109559A 2003-06-24 2006-08-28 Processes for the preparation of 1-[(benzoimidazole-1yl)quinolin-8-yl] piperidin-4-ylamine derivatives HK1089170A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48217603P 2003-06-24 2003-06-24
PCT/IB2004/001983 WO2004113322A1 (en) 2003-06-24 2004-06-14 Processes for the preparation of 1-[(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives

Publications (1)

Publication Number Publication Date
HK1089170A1 true HK1089170A1 (en) 2006-11-24

Family

ID=33539339

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06109559A HK1089170A1 (en) 2003-06-24 2006-08-28 Processes for the preparation of 1-[(benzoimidazole-1yl)quinolin-8-yl] piperidin-4-ylamine derivatives

Country Status (25)

Country Link
US (2) US7183414B2 (xx)
EP (1) EP1641780B1 (xx)
JP (1) JP2007516168A (xx)
KR (2) KR20070092333A (xx)
CN (1) CN100404530C (xx)
AR (1) AR044849A1 (xx)
AT (1) ATE414077T1 (xx)
AU (1) AU2004249511B2 (xx)
BR (1) BRPI0411794A (xx)
CA (1) CA2529032C (xx)
CL (1) CL2004001470A1 (xx)
CO (1) CO5650165A2 (xx)
DE (1) DE602004017731D1 (xx)
DK (1) DK1641780T3 (xx)
ES (1) ES2315663T3 (xx)
HK (1) HK1089170A1 (xx)
IL (1) IL172064A (xx)
MX (1) MXPA05014203A (xx)
NO (1) NO20060376L (xx)
NZ (2) NZ543714A (xx)
RU (1) RU2323214C2 (xx)
SG (1) SG161745A1 (xx)
TW (1) TWI294425B (xx)
WO (1) WO2004113322A1 (xx)
ZA (1) ZA200509253B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0411421D0 (en) * 2004-05-21 2004-06-23 Glaxo Group Ltd Novel compounds
WO2006038111A1 (en) * 2004-10-07 2006-04-13 Pfizer Products Inc. Benzoimidazole derivatives useful as antiproliferative agents
RU2007140903A (ru) * 2005-04-05 2009-05-20 Фармакопия, Инк. (Us) Производные пурина и имидазопиридина для иммуносупрессии
US7504513B2 (en) 2006-02-27 2009-03-17 Hoffman-La Roche Inc. Thiazolyl-benzimidazoles
CA2731368C (en) 2008-08-06 2013-05-14 Pfizer Inc. 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors
CA2745596A1 (en) 2008-12-18 2010-10-28 F. Hoffmann-La Roche Ag Thiazolyl-benzimidazoles
CN101993416B (zh) * 2009-08-27 2013-09-11 中国科学院上海药物研究所 喹啉类化合物、其制备方法、包含该化合物的药物组合物及该化合物的用途
KR101738063B1 (ko) 2012-09-21 2017-05-19 아로그 파마슈티칼스, 인코퍼레이티드 구조적으로 활성인 인산화된 ｆｌｔ３ 키나제의 억제 방법
US10835525B2 (en) 2012-09-26 2020-11-17 Arog Pharmaceuticals, Inc. Method of inhibiting mutant C-KIT
US11642340B2 (en) 2012-09-26 2023-05-09 Arog Pharmaceuticals, Inc. Method of inhibiting mutant C-KIT
TWI599356B (zh) 2012-09-26 2017-09-21 安羅格製藥有限責任公司 抑制突變型ｃ－ｋｉｔ的方法
BR112015016282A2 (pt) 2013-01-07 2017-07-11 Arog Pharmaceuticals Inc crenolanibe para tratamento de distúrbios proliferativos de flt3 mutado
US10463658B2 (en) 2013-10-25 2019-11-05 Videra Pharmaceuticals, Llc Method of inhibiting FLT3 kinase
US11078541B2 (en) 2016-11-02 2021-08-03 Arog Pharmaceuticals, Inc. Crenolanib for treating FLT3 mutated proliferative disorders associated mutations
CN107382983B (zh) * 2017-08-24 2020-08-07 扬州市三药制药有限公司 一种治疗白血病药物的合成方法
CN107382984B (zh) * 2017-08-24 2020-07-10 扬州市三药制药有限公司 一种治疗白血病药物的制备方法
CN110840893A (zh) 2018-12-13 2020-02-28 安罗格制药有限责任公司 含克莱拉尼的药物组合物及其用途
CN109678849A (zh) * 2019-01-16 2019-04-26 北京悦康科创医药科技股份有限公司 一种抗癌药物的制备方法
US11471451B2 (en) 2019-08-19 2022-10-18 Arog Pharmaceuticals, Inc. Uses of crenolanib
CN113024435B (zh) * 2019-12-09 2022-06-17 苏州恩华生物医药科技有限公司 连双环结构sigma-1受体抑制剂
WO2022019998A1 (en) * 2020-07-20 2022-01-27 Arog Pharmaceuticals, Inc. Crystal forms of crenolanib and methods of use thereof
US11524006B2 (en) 2020-09-17 2022-12-13 Arog Pharmaceuticals, Inc. Crenolanib for treating TRK kinase associated proliferative disorders
US20220079934A1 (en) * 2020-09-17 2022-03-17 Arog Pharmaceuticals, Inc. Crenolanib for treating pain
US11969420B2 (en) 2020-10-30 2024-04-30 Arog Pharmaceuticals, Inc. Combination therapy of crenolanib and apoptosis pathway agents for the treatment of proliferative disorders
CN113683594B (zh) * 2021-09-07 2022-12-27 曲靖师范学院 一种喹啉-苯并咪唑盐类化合物及其合成方法和应用
JP2023063189A (ja) 2021-10-22 2023-05-09 アログ・ファーマシューティカルズ・インコーポレイテッド 以前の治療に対して再発性／不応性のｆｌｔ３突然変異増殖性障害を治療するためのクレノラニブ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE390404T1 (de) * 1997-02-27 2008-04-15 Takeda Pharmaceutical Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta
UA75055C2 (uk) * 1999-11-30 2006-03-15 Пфайзер Продактс Інк. Похідні бензоімідазолу, що використовуються як антипроліферативний засіб, фармацевтична композиція на їх основі
JP4554135B2 (ja) * 1999-12-10 2010-09-29 富士フイルム株式会社 インクジェットヘッドおよび印刷装置
EP1321454A4 (en) * 2000-09-14 2005-11-02 Kaneka Corp PROCESS FOR EXTRACTING NITROBENZENESULFONYL
PA8580301A1 (es) * 2002-08-28 2005-05-24 Pfizer Prod Inc Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos

Also Published As

Publication number Publication date
CN100404530C (zh) 2008-07-23
RU2005138367A (ru) 2006-08-10
CA2529032C (en) 2009-12-22
KR20060012033A (ko) 2006-02-06
KR100787649B1 (ko) 2007-12-21
NO20060376L (no) 2006-01-24
AU2004249511A1 (en) 2004-12-29
BRPI0411794A (pt) 2006-08-08
EP1641780B1 (en) 2008-11-12
US20050020625A1 (en) 2005-01-27
CO5650165A2 (es) 2006-06-30
AU2004249511B2 (en) 2011-01-20
ZA200509253B (en) 2007-01-31
CA2529032A1 (en) 2004-12-29
TW200517393A (en) 2005-06-01
NZ543714A (en) 2009-06-26
TWI294425B (en) 2008-03-11
DE602004017731D1 (de) 2008-12-24
DK1641780T3 (da) 2009-02-02
ATE414077T1 (de) 2008-11-15
IL172064A (en) 2011-01-31
MXPA05014203A (es) 2006-02-24
CL2004001470A1 (es) 2005-05-13
NZ571898A (en) 2010-01-29
ES2315663T3 (es) 2009-04-01
SG161745A1 (en) 2010-06-29
RU2323214C2 (ru) 2008-04-27
US20070088032A1 (en) 2007-04-19
EP1641780A1 (en) 2006-04-05
WO2004113322A1 (en) 2004-12-29
KR20070092333A (ko) 2007-09-12
AR044849A1 (es) 2005-10-05
CN1809556A (zh) 2006-07-26
US7183414B2 (en) 2007-02-27
JP2007516168A (ja) 2007-06-21

Similar Documents

Publication Publication Date Title
HK1089170A1 (en) Processes for the preparation of 1-[(benzoimidazole-1yl)quinolin-8-yl] piperidin-4-ylamine derivatives
IL189657A (en) Process for the preparation of n-phenyl-2-pyrimidine-amine derivatives
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
IL175947A0 (en) Novel quinoline derivatives
HK1085480A1 (en) Process for the preparation of roflumilast
IL164324A0 (en) Quinolinone derivatives
IL169500A0 (en) Pyrrolopyridazine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HRP20150163T1 (xx) Postupak za proizvodnju n-supstituiranih 2-cijanopirolidina
HK1087720A1 (en) Method for preparing echinocandin derivatives
IL175743A0 (en) Process for the preparation of thiazolopyrimidines
IL171789A (en) Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
TWI340745B (en) Novel diketopiperazine derivatives and the processes for preparation thereof
HK1071364A1 (en) Quinoline derivatives
EP1646640A4 (en) PROCESS FOR PREPARING HIGH-PURITY 1-ANDROSTEN DERIVATIVES
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
AU2003281698A8 (en) 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
HK1095145A1 (en) Process for the preparation of n-arylmorpholinones n-
PL378180A1 (pl) Złożony preparat przeciwko zawrotom głowy
EP1487799A4 (en) 9-AMINOACRIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
AU2003224421A1 (en) Process for the preparation of loratadine
ZA200603113B (en) Process for the preparation of risperidone
EP1451178A4 (en) PROCESS FOR PREPARING BEAT D RIBOFURANOSE DERIVATIVES
HK1087111A1 (en) Process for the preparation of nicotinaldehydes
HUP0300255A3 (en) Process for the preparation of 2-phenyl-4-methyl-1-tosil-piperazine

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210614